Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes

Clinical and Experimental Immunology

Volumn 177, Issue 3, 2014, Pages 571-585

  Thompson, W S ^a   Pekalski, M L ^a   Simons, H Z ^a   Smyth, D J ^a   Castro Dopico, X ^a   Guo, H ^a   Guy, C ^b   Dunger, D B ^b   Arif, S ^c   Peakman, M ^c   Wallace, C ^a   Wicker, L S ^a   Todd, J A ^a   Ferreira, R C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

B lymphocytes; Human immunology; IL 2; IL 21; Immunophenotyping; PTPN22; Type 1 diabetes

Indexed keywords

CD19 ANTIGEN; CD24 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 21;

ADULT; ALLELE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; PRIORITY JOURNAL;

B LYMPHOCYTES; HUMAN IMMUNOLOGY; IL-2; IL-21; IMMUNOPHENOTYPING; PTPN22; TYPE 1 DIABETES;

ADOLESCENT; ADULT; AGE FACTORS; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; CASE-CONTROL STUDIES; CHILD; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNOPHENOTYPING; MALE; PHENOTYPE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84904740187     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12362     Document Type: Article

References (47)

1. Todd JA. Etiology of type 1 diabetes. Immunity 2010; 32:457-467.
2. Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell 2011; 147:44-56.
3. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009; 155:173-181.
4. Rowe P, Campbell-Thompson M, Schatz D, Atkinson M. The pancreas in human type 1 diabetes. Semin Immunopathol 2011; 33:29-43.
5. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009; 360:1646-1654.
6. Barrett JC, Clayton DG, Concannon P etal. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41:703-707.
7. Wallace C, Smyth DJ, Maisuria-Armer M, Walker NM, Todd JA, Clayton DG. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet 2010; 42:68-71.
8. Serreze DV, Chapman HD, Varnum DS etal. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new 'speed congenic' stock of NOD.Ig mu null mice. J Exp Med 1996; 184:2049-2053.
9. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998; 161:3912-3918.
10. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997; 46:941-946.
11. Noorchashm H, Lieu YK, Noorchashm N etal. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice. J Immunol 1999; 163:743-750.
12. Hu C-, Rodriguez-Pinto D, Du W etal. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 2007; 117:3857-3867.
13. Ziegler A, Rewers M, Simell O etal. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013; 309:2473-2479.
14. Plagnol V, Howson JMM, Smyth DJ etal. Type 1 diabetes genetics C. genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011; 7:e1002216.
15. Howson JMM, Krause S, Stevens H etal. Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases. Diabetologia 2012; 55:1978-1984.
16. Silveira PA, Johnson E, Chapman HD, Bui T, Tisch RM, Serreze DV. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol 2002; 32:3657-3666.
17. Xiu Y, Wong CP, Bouaziz J-D etal. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in FcγR effector functions. J Immunol 2008; 180:2863-2875.
18. Blair PA, Noreña LY, Flores-Borja F etal. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010; 32:129-140.
19. Iwata Y, Matsushita T, Horikawa M etal. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011; 117:530-541.
20. Yoshizaki A, Miyagaki T, DiLillo DJ etal. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012; 491:264-268.
21. Flores-Borja F, Bosma A, Ng D etal. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 2013; 5:173ra23.
22. Yang M, Rui K, Wang S, Lu L. Regulatory B cells in autoimmune diseases. Cell Mol Immunol 2013; 10:122-132.
23. Li X, Zhong H, Bao W etal. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood 2012; 120:3318-3325.
24. Habib T, Funk A, Rieck M etal. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol 2012; 188:487-496.
25. Arechiga AF, Habib T, He Y etal. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 2009; 182:3343-3347.
26. Menard L, Saadoun D, Isnardi I etal. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest 2011; 121:3635-3644.
27. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002; 100:4537-4543.
28. Yanaba K, Bouaziz J-D, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009; 182:7459-7472.
29. De Filippo G, Pozzi N, Cosentini E etal. Increased CD5+CD19+ B lymphocytes at the onset of type 1 diabetes in children. Acta Diabetol 1997; 34:271-274.
30. Dendrou CA, Plagnol V, Fung E etal. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet 2009; 41:1011-1015.
31. Arif S, Tree TI, Astill TP etal. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113:451-463.
32. Herold KC, Brooks-Worrell B, Palmer J etal., Group tTDTR. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 2009; 58:2588-2595.
33. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013. Available at: http://cran.r-project.org.
34. Champely S. pwr. Basic functions for power analysis. R package version 1.1.1. 2012. Available at: http://cran.r-project.org/web/packages/pwr/.
35. Veneri D, Ortolani R, Franchini M, Tridente G, Pizzolo G, Vella A. Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages. Blood Transfus 2009; 7:29-34.
36. Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol 2010; 162:271-279.
37. Macallan DC, Wallace DL, Zhang Y etal. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 2005; 105:3633-3640.
38. Duggal NA, Upton J, Phillips AC, Sapey E, Lord JM. An age-related numerical and functional deficit in CD19+CD24hiCD38hiB cells is associated with an increase in systemic autoimmunity. Aging Cell 2013; 12:873-881.
39. Raveche ES. Possible immunoregulatory role for CD5+ B cells. Clin Immunol Immunopathol 1990; 56:135-150.
40. Caruso C, Lio D, Cavallone L, Franceschi C. Aging, longevity, inflammation, and cancer. Ann NY Acad Sci 2004; 1028:1-13.
41. Sarkar D, Fisher PB. Molecular mechanisms of aging-associated inflammation. Cancer Lett 2006; 236:13-23.
42. Palanichamy A, Barnard J, Zheng B etal. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol 2009; 182:5982-5993.
43. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H etal. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009; 361:2143-2152.
44. Martin S, Wolf-Eichbaum D, Duinkerken G etal. Development of type 1 diabetes despite severe hereditary B-cell deficiency. N Engl J Med 2001; 345:1036-1040.
45. Tree TIM, Lawson J, Edwards H etal. Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression. Diabetes 2010; 59:1451-1460.
46. Itoh K, Inoue T, Ito K, Hirohata S. The interplay of interleukin-10 (IL-10) and interleukin-2 (IL-2) in humoral immune responses: IL-10 synergizes with IL-2 to enhance responses of human B lymphocytes in a mechanism which is different from upregulation of CD25 expression. Cell Immunol 1994; 157:478-488.
47. Spolski R, Kim H-P, Zhu W, Levy DE, Leonard WJ. IL-21 mediates suppressive effects via its induction of IL-10. J Immunol 2009; 182:2859-2867.